Literature DB >> 22166222

Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Ji-Dong Guo1, Rimi Hazra, Joanna Dabrowska, E Chris Muly, Jürgen Wess, Donald G Rainnie.   

Abstract

The anterolateral cell group of the bed nucleus of the stria terminalis (BNST(ALG)) serves as an important relay station in stress circuitry. Limbic inputs to the BNST(ALG) are primarily glutamatergic and activity-dependent changes in this input have been implicated in abnormal behaviors associated with chronic stress and addiction. Significantly, local infusion of acetylcholine (ACh) receptor agonists into the BNST trigger stress-like cardiovascular responses, however, little is known about the effects of these agents on glutamatergic transmission in the BNST(ALG). Here, we show that glutamate- and ACh-containing fibers are found in close association in the BNST(ALG). Moreover, in the presence of the acetylcholinesterase inhibitor, eserine, endogenous ACh release evoked a long-lasting reduction of the amplitude of stimulus-evoked EPSCs. This effect was mimicked by exogenous application of the ACh analog, carbachol, which caused a reversible, dose-dependent, reduction of the evoked EPSC amplitude, and an increase in both the paired-pulse ratio and coefficient of variation, suggesting a presynaptic site of action. Uncoupling of postsynaptic G-proteins with intracellular GDP-β-S, or application of the nicotinic receptor antagonist, tubocurarine, failed to block the carbachol effect. In contrast, the carbachol effect was blocked by prior application of atropine or M(2) receptor-preferring antagonists, and was absent in M(2)/M(4) receptor knockout mice, suggesting that presynaptic M(2) receptors mediate the effect of ACh. Immunoelectron microscopy studies further revealed the presence of M(2) receptors on axon terminals that formed asymmetric synapses with BNST neurons. Our findings suggest that presynaptic M(2) receptors might be an important modulator of the stress circuit and hence a novel target for drug development.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22166222      PMCID: PMC3269526          DOI: 10.1016/j.neuropharm.2011.11.013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  82 in total

1.  Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

Authors:  Weilie Zhang; Masahisa Yamada; Jesus Gomeza; Anthony S Basile; Jürgen Wess
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

2.  Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.

Authors:  H Kubista; K Kosenburger; P Mahlknecht; H Drobny; S Boehm
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

3.  Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.

Authors:  Dara M Cannon; Richard E Carson; Allison C Nugent; William C Eckelman; Dale O Kiesewetter; Joan Williams; Denise Rollis; Michele Drevets; Shilpa Gandhi; Gerardo Solorio; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2006-07

4.  Distribution of muscarinic cholinergic high and low affinity agonist binding sites: a light microscopic autoradiographic study.

Authors:  J K Wamsley; M A Zarbin; M J Kuhar
Journal:  Brain Res Bull       Date:  1984-03       Impact factor: 4.077

5.  Muscarinic inhibition of glutamatergic transmissions onto rat magnocellular basal forebrain neurons in a thin-slice preparation.

Authors:  J A Sim; W H Griffith
Journal:  Eur J Neurosci       Date:  1996-05       Impact factor: 3.386

6.  Cardiovascular effects of carbachol microinjected into the bed nucleus of the stria terminalis of the rat brain.

Authors:  F H F Alves; C C Crestani; L B M Resstel; F M A Corrêa
Journal:  Brain Res       Date:  2007-01-25       Impact factor: 3.252

7.  Muscarinic receptor subtypes in the lateral geniculate nucleus: a light and electron microscopic analysis.

Authors:  K L Plummer; K A Manning; A I Levey; H D Rees; D J Uhlrich
Journal:  J Comp Neurol       Date:  1999-02-15       Impact factor: 3.215

8.  Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Authors:  A S Gibbons; E Scarr; C McLean; S Sundram; B Dean
Journal:  J Affect Disord       Date:  2008-12-21       Impact factor: 4.839

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections.

Authors:  D G Spencer; E Horváth; J Traber
Journal:  Brain Res       Date:  1986-08-13       Impact factor: 3.252

View more
  11 in total

1.  Contrasting distribution of physiological cell types in different regions of the bed nucleus of the stria terminalis.

Authors:  Olga E Rodríguez-Sierra; Hjalmar K Turesson; Denis Pare
Journal:  J Neurophysiol       Date:  2013-08-07       Impact factor: 2.714

Review 2.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

3.  Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.

Authors:  Marissa A Smail; Jessica L Soles; Tracy E Karwoski; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2017-11-07       Impact factor: 4.077

4.  Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction.

Authors:  Georgette M Gafford; Ji-Dong Guo; Elizabeth I Flandreau; Rimi Hazra; Donald G Rainnie; Kerry J Ressler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-19       Impact factor: 11.205

5.  Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2016-04-21       Impact factor: 3.215

6.  Serotonin gating of cortical and thalamic glutamate inputs onto principal neurons of the basolateral amygdala.

Authors:  Ji-Dong Guo; Brendan M O'Flaherty; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

7.  Distribution and functional expression of Kv4 family α subunits and associated KChIP β subunits in the bed nucleus of the stria terminalis.

Authors:  Donald G Rainnie; Rimi Hazra; Joanna Dabrowska; Ji-Dong Guo; Chen Chen Li; Sarah Dewitt; E Chris Muly
Journal:  J Comp Neurol       Date:  2014-02-15       Impact factor: 3.215

8.  Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review.

Authors:  Carlos C Crestani; Fernando Hf Alves; Felipe V Gomes; Leonardo Bm Resstel; Fernando Ma Correa; James P Herman
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

9.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

Review 10.  Axo-axonic synapses: Diversity in neural circuit function.

Authors:  Kara K Cover; Brian N Mathur
Journal:  J Comp Neurol       Date:  2020-12-18       Impact factor: 3.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.